Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. - Wikidata - awgldk - TriplyDB

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

http://www.wikidata.org/entity/Q34600272

about

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.Allogeneic natural killer cells for refractory lymphoma Adaptive control of innate immunity.Hematopoietic progenitor cell regulation by CD4+CD25+ T cells.Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells.Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation Activated mouse CD4(+)Foxp3(-) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity.Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.T cell regulation of natural killer cells.Inhibition of lung metastasis by chemokine CCL17-mediated in vivo silencing of genes in CCR4+ Tregs.Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting.Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.Use of allogeneic NK cells for cancer immunotherapy.Natural killer cell immune escape in acute myeloid leukemia.The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.Natural killer cells in asthma Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.Interactions between innate and adaptive lymphocytes.NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors.

P2860

Q26751011-EFA27655-9D80-480C-A384-9187D7C8D548 Q26765845-73F6D86A-33EC-4AE9-BBB0-9CC0A94B8B93 Q27001081-D7EA6BAC-E0EF-4381-8626-614C629D6786 Q27008625-5CA3EDE3-F886-4134-AD31-5237B9BB72D1 Q28078949-96B36618-3EE8-458D-8D33-ECAFB3A8B9CD Q33330270-3C537E24-D098-4C17-B2F8-CA11AED1BD3C Q33734571-50346BC1-340D-403B-BC41-3F8F63020804 Q33850138-F0E47F11-0596-4351-BF35-C1F1493B443F Q33912853-D17F380F-E643-40C1-A51F-63BD816ABB18 Q33931910-DD9B2078-742B-4B3A-B8E1-D0C45D7455D3 Q34563034-B69242C6-6C8A-4C27-B333-19B20C8C75B0 Q34651540-089EEB52-BDFA-45E1-93CD-5EAF9ECC25E0 Q35553553-DBBB2A8C-41D8-4E64-9D9B-6A3A85480D11 Q35887296-E4E2C44C-B0E1-4B1D-8153-F5AA73920F08 Q35915642-1BDA8E3F-92B1-41ED-B7BE-47892E6B3492 Q36279520-413C9D31-0ABE-48AB-96EC-007484152111 Q36423437-6EBE106F-0E5E-4594-9C5A-7F2039E75A7B Q36449146-4CCD5D53-95C3-427C-9E54-D4314F83D4B7 Q36668089-D3704859-478A-431D-914B-878DC64FC47B Q36692284-DB353998-250E-4AC3-9B3C-92454A2A21E6 Q36820198-23763288-B3B1-4A86-93F7-710305934ADD Q36907905-1B5C2209-3E8C-460E-8E26-524CC791789F Q37000445-265BF5DE-0A51-4A4A-A07E-BD0F1D0FF54F Q37066280-DB716896-C09B-4EE6-AF37-3AEDF1CACA1F Q37178190-901B5997-B62E-4FFF-AD8E-5557C9ED55E6 Q37228646-17C3C5D1-D5DA-4119-9633-25E985FD41DC Q37234615-641B1B0D-D6A3-4766-9320-C65882483C1C Q37256962-4959FAB8-CFBA-4F1B-AA88-6893F5CB10A6 Q37327064-6BD73AA9-0D0B-45E1-B991-234D8092F4FE Q37346143-16E2AE96-8338-4818-B020-EB063AC43FB0 Q37389994-A43EDF89-4FAB-4188-8748-2734A8D96F8D Q37595721-08210E85-1603-46E0-A54A-8C948439E150 Q37776637-BE91F027-7739-45B2-8E11-ED1A789FA983 Q37957140-990101D4-18C1-4F5B-B251-2460A079ACD9 Q37996816-486C1E3A-8763-42D8-80C2-4CE11D14E779 Q38073762-C09BC63E-4CBD-4C68-9E34-429BCA2546D1 Q38117142-CC6170AF-3BC9-4B99-84F4-FA32B9573B43 Q38155240-51AC2426-A25A-47E2-8801-A9D8CCBB3DFD Q38240762-E76339E6-6828-4BE3-B2B2-A3324D828C15 Q38362633-2FB8AD21-045D-48B0-81D3-85211116DE40

P2860

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

http://www.wikidata.org/entity/Q34600272

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@ast

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@en

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@nl

type

label

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@ast

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@en

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@nl

prefLabel

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@ast

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@en

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@nl

P1433

Q34600272-91358A2D-B7F3-4719-8F4A-F4CDA09EF83F

P1476

Q34600272-53EC824F-D36E-48AB-92C1-E3BF50D36262

P2093

Q34600272-151F5F2C-45FF-4997-BCA9-581E1A7DCA75

Q34600272-6B996568-8E51-49DB-80D1-47B7B4E05024

Q34600272-8177434B-F272-4AF3-AD5E-AD47DB5A5D3F

Q34600272-9CAEF9E0-BF2B-431F-AA0E-713030FAA21A

Q34600272-B0D1B836-EA63-4866-B15F-7F2233C951FF

Q34600272-E2EDCB14-CE7B-4251-BC98-BBE5497C47C0

Q34600272-F17A6570-7BCF-43F5-930F-CFCD50CCFD16

P2860

Q34600272-0684A261-08BE-42C3-8C5B-714DA6D094D3

Q34600272-17D3A5B6-BC36-4029-A5E1-F5BA1D279C4D

Q34600272-22014E26-ABB2-4274-BEE7-76DD2D8EA655

Q34600272-3E552500-4103-482D-A47C-BA0386DCA404

Q34600272-3FE10F94-A456-413C-9E7F-9198D7A50A59

Q34600272-46824903-842C-4E4E-983C-E4515429B979

Q34600272-46BA9A2D-7236-4A3F-B36E-73A0903D704F

Q34600272-4C207190-AB82-4E8A-9BD8-10CB64EE53BE

Q34600272-58C909E3-660B-42C0-B636-B60928AD2A3B

Q34600272-596EC78F-32BE-4C13-ACD4-2B614BBAC46D

P304

Q34600272-2F6EFE31-46CA-4326-ACC8-AD876D63105D

P31

Q34600272-C333F21C-2DE0-40BC-B6A8-83C1E4565DF2

P356

Q34600272-135C6240-B3CB-4C85-B21A-978C7C9CB007

P407

Q34600272-23F65C0E-4EB9-4446-A9E3-A288623C3772

P433

Q34600272-666D87CB-C3D8-4BA9-9F47-3BA50966B602

P478

Q34600272-61383C92-88C7-417F-9A66-9DAC7B1E7CDA

P50

Q34600272-7457d7ab-4d2d-40a1-e3ba-3c727702aac7

Q34600272-86295F37-98E8-4175-AA0A-8074BA59180B

P577

Q34600272-7EC29CC5-5B5E-4973-A1DC-70FCFD0DA776

P5875

Q34600272-866BC551-24ED-43CD-B21D-840134DBD022

P698

Q34600272-B267B6E4-D685-401B-84B6-F5E0456D32BE

P921

Q34600272-791F2552-0257-4152-BED5-D9F386FE1614

P932

Q34600272-AC939664-E95B-47D1-AD08-C6565E8490F9

P356

PNAS.0509249103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Suppression of natural killer ...... CD4+CD25+ regulatory T cells.

@en

P2093

Alan M Hanash

http://www.w3.org/2001/XMLSchema#string

Isabel Barao

http://www.w3.org/2001/XMLSchema#string

Kai Sun

http://www.w3.org/2001/XMLSchema#string

Lisbeth A Welniak

http://www.w3.org/2001/XMLSchema#string

Robert B Levy

http://www.w3.org/2001/XMLSchema#string

William Hallett

http://www.w3.org/2001/XMLSchema#string

William J Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Control of regulatory T cell development by the transcription factor Foxp3

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

Biology of natural killer cells

Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo.

Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Regulatory T cells in autoimmmunity*.

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.

P304

5460-5465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0509249103

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Douglas D. Redelman

P577

2006-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7210950

http://www.w3.org/2001/XMLSchema#string

P698

16567639

http://www.w3.org/2001/XMLSchema#string

P921

P932

1459377

http://www.w3.org/2001/XMLSchema#string